… Although multiple therapies have been shown to lower mortality in patients with heart failure
(HF) and reduced left ventricular ejection fraction, their application in clinical practice has …

… history of therapy for heart failure with reduced ejection fraction began with the introduction of
vasodilatation as a treatment for heart failure. … of heart failure to a level unimaginable today. …

… Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Management of
HF involves accurate diagnosis … Therapies for advanced heart failure Heart transplantation …

Evidence-based consensus treatment guidelines are available to assist physicians with the
management of chronic heart failure (HF). Although it has been generally presumed that …

… antihyperglycemic therapies … therapies on HF and discusses potential mechanisms for
beneficial or deleterious effects. Second, we review currently approved pharmacological therapies …

… with allocation of advanced heart failure therapies in this study, there was evidence of bias,
which could contribute to delayed and lower allocation of advanced therapies to women. …

… After an initial higher mortality rate after transplantation, overall one-year survival is comparable
to medical therapy for patients in the current era and better than heart failure therapy in …

… making, but its impact on advanced heart failure therapy allocation is unknown. We sought
to determine whether patient race influences allocation of advanced heart failure therapies. …

Background— A treatment gap exists between heart failure (HF) guidelines and the clinical
care of patients. The Registry to Improve the Use of Evidence-Based Heart Failure Therapies …

… At baseline, a high percentage of patients were receiving the recommended heart failure
therapy (Table 1). Uptitration of therapy to reduce symptoms was recommended in 192 patients …